AirSculpt Technologies Stock Plummets 43% Following Q3 Revenue Decrease and Reduced Forecast
Stock Performance: AirSculpt Technologies, Inc. (AIRS) experienced a significant drop of 42.76% in stock price, falling to $6.01 after disappointing third-quarter fiscal 2025 results.
Financial Results: The company reported a revenue of $35.0 million, a 17.8% decrease Year-over-Year, and an expanded net loss of $9.5 million compared to a loss of $6.0 million the previous year.
Revised Outlook: AirSculpt lowered its full-year 2025 revenue forecast to approximately $153 million from an earlier estimate of $160-$170 million, indicating weaker demand in the body-contouring market.
Market Reaction: Following the announcement, AIRS experienced heavy trading volume as investors reacted to the growth miss and reduced guidance, with the stock's 52-week range noted between $2.60 and $12.50.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on AIRS
About AIRS
About the author
Friday's Underperforming Sectors: Construction, Healthcare, and Medical Professionals
Market Performance: Hospital and medical practitioners' shares are down approximately 1.7% on Friday, with Agilon Health and AirSculpt Technologies leading the decline at 9% and 8.3%, respectively.
Sector Laggards: The construction sector, along with hospital and medical practitioners, is identified as a laggard in the market on Friday.
Video Coverage: A video segment highlights the performance of these sectors, focusing on the laggards in the market.
Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Three Health Care Stocks That Could Revitalize Your Portfolio This November
Oversold Stocks in Health Care: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Inotiv Inc Performance: Inotiv Inc reported strong contract awards and anticipates fourth-quarter revenue between $137.5 million and $138.5 million, despite its stock falling 38% recently, with an RSI of 26.7.
Airsculpt Technologies Update: Airsculpt Technologies faced disappointing third-quarter results and lowered its FY25 revenue outlook, leading to a 60% stock drop over the past month, with an RSI of 29.3.
Neuronetics Sales Guidance: Neuronetics cut its FY2025 sales guidance, resulting in a 40% decline in stock value over the past month, and it currently has an RSI of 23.9.
